Business Description
ACI Formulations PLC
ISIN : BD0480ACIFL4
Total Employee Number:
994Compare
Compare
Traded in other countries / regions
ACIFORMULA.Bangladesh IPO Date
2008-11-18Description
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.1 | |||||
Debt-to-EBITDA | 5.55 | |||||
Interest Coverage | 2.68 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 2.18 | |||||
Beneish M-Score | -2.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year EBITDA Growth Rate | 16.8 | |||||
3-Year EPS without NRI Growth Rate | 14.8 | |||||
3-Year Book Growth Rate | 4.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.58 | |||||
9-Day RSI | 53.89 | |||||
14-Day RSI | 58.5 | |||||
3-1 Month Momentum % | 4.27 | |||||
6-1 Month Momentum % | 13.9 | |||||
12-1 Month Momentum % | 5.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.24 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 138.21 | |||||
Days Sales Outstanding | 111.75 | |||||
Days Payable | 11.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.44 | |||||
Dividend Payout Ratio | 0.34 | |||||
3-Year Dividend Growth Rate | -12.6 | |||||
Forward Dividend Yield % | 1.44 | |||||
5-Year Yield-on-Cost % | 1.1 | |||||
Shareholder Yield % | -6.37 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 30.83 | |||||
Operating Margin % | 11.65 | |||||
Net Margin % | 6.32 | |||||
EBITDA Margin % | 13.67 | |||||
FCF Margin % | -12.59 | |||||
OCF Margin % | -8.19 | |||||
ROE % | 9.59 | |||||
ROA % | 3.94 | |||||
ROIC % | 6.15 | |||||
3-Year ROIIC % | 11.56 | |||||
ROC (Joel Greenblatt) % | 12.65 | |||||
ROCE % | 17.93 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.76 | |||||
PE Ratio without NRI | 22.76 | |||||
Shiller PE Ratio | 28.85 | |||||
PEG Ratio | 1.65 | |||||
PS Ratio | 1.44 | |||||
PB Ratio | 2.09 | |||||
Price-to-Tangible-Book | 2.09 | |||||
EV-to-EBIT | 17.31 | |||||
EV-to-EBITDA | 16.15 | |||||
EV-to-Revenue | 2.21 | |||||
EV-to-FCF | -17.61 | |||||
Price-to-GF-Value | 1.13 | |||||
Price-to-Projected-FCF | 1.68 | |||||
Price-to-DCF (Earnings Based) | 1.86 | |||||
Price-to-Median-PS-Value | 0.92 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.73 | |||||
Price-to-Graham-Number | 1.45 | |||||
| Price-to-Net-Current-Asset-Value | 8.4 | |||||
Earnings Yield (Greenblatt) % | 5.78 | |||||
FCF Yield % | -8.65 | |||||
Forward Rate of Return (Yacktman) % | 13.97 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ACI Formulations PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 5,577.38 | ||
| EPS (TTM) (BDT) | 7.45 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.09 | ||
| Volatility % | 28.22 | ||
| 14-Day RSI | 58.5 | ||
| 14-Day ATR (BDT) | 5.763341 | ||
| 20-Day SMA (BDT) | 163.075 | ||
| 12-1 Month Momentum % | 5.52 | ||
| 52-Week Range (BDT) | 115 - 189.2 | ||
| Shares Outstanding (Mil) | 47.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ACI Formulations PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ACI Formulations PLC Stock Events
| Event | Date | Price (BDT) | ||
|---|---|---|---|---|
| BDT 2.500000 Cash Dividend | 2025-11-20 | 125.40 (+0.00%) | ||
| BDT 2.000000 Cash Dividend | 2024-11-18 | 120.20 (+0.00%) | ||
| 1.05:1 Stock Split | 2021-11-21 | 154.95 (+0.00%) | ||
| 1.5:1 Stock Split | 2012-05-17 | 93.84 (+0.00%) |
Show
Entries
ACI Formulations PLC Frequently Asked Questions
What is ACI Formulations PLC(DHA:ACIFORMULA)'s stock price today?
The current price of DHA:ACIFORMULA is BDT172.00. The 52 week high of DHA:ACIFORMULA is BDT189.20 and 52 week low is BDT115.00.
When is next earnings date of ACI Formulations PLC(DHA:ACIFORMULA)?
The next earnings date of ACI Formulations PLC(DHA:ACIFORMULA) is .
Does ACI Formulations PLC(DHA:ACIFORMULA) pay dividends? If so, how much?
The Dividend Yield %  of ACI Formulations PLC(DHA:ACIFORMULA) is 1.44% (As of Today), Highest Dividend Payout Ratio of ACI Formulations PLC(DHA:ACIFORMULA) was 1.7. The lowest was 0.26. And the median was 0.54. The  Forward Dividend Yield % of ACI Formulations PLC(DHA:ACIFORMULA) is 1.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ACI Formulations PLC
No articles.